Eaton Vance Management Coherus Bio Sciences, Inc. Transaction History

Eaton Vance Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$10.92 - $16.41 $9,205 - $13,833	-843 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.81 - $18.99 $2,371 - $2,848	150 Added 21.65%	843 $0
Q3 2021 Nov 15, 2021	BUY	$12.68 - $17.79 $2,497 - $3,504	197 Added 39.72%	693 $3,000
Q2 2021 Aug 16, 2021	BUY	$12.95 - $15.41 $4,195 - $4,992	324 Added 188.37%	496 $7,000
Q1 2021 May 17, 2021	BUY	$14.42 - $21.39 $2,480 - $3,679	172 New	172 $3,000

137

78M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $96.4M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.